University of Evansville
Page _____ of ______
Department of Nursing and Health Sciences
Drug Dispensing Sheet
Student _______Tammy Barton________________
Date______________09/29/2009_______
Allergies:
Priority Nursing Diagnosis:
Long and Short term goals (must be measurable):
MEDICATION WITH
INDIVIDUAL DESIRED
PRESCRIBED DOSEAGE
EFFECT OF DRUG FOR
CLASSIFICATION OF THE
THIS PATIENT
DRUG
USUAL DOSE/SAFE DOSE
AND ADMINISTRATION
Name Brand: Morphine
Decrease severity of pain after
having surgery without
Generic Name:
Classification: Opioids
significant alteration in level of
analgesics, opioids agonists
consciousness or respiratory
status.
Dosage: 0.8-10mg/hr
Availability: (PCA device)
1mg/ml, 2mg/ml, 3mg/ml,
5mg/ml
NURSING IMPLICATIONS/
CONSIDERATIONS FOR
THIS PATIENT
EVALUATION OF DESIRED
EFFECT FOR THE PATIENT.
INCLUDING ASSESSMENT,
LAB RESULTS AND
PROCEDURES
Asses type, location, and
intensity of pain, prior to and
after administration.
May increase plasma amylase
and lipase levels
Assess level of consciousness,
blood pressure, pulse and
respiration before and
periodically during
administration
If respiration <10 assess level
of sedation. Physical
stimulation may be sufficient to
prevent significant
hypoventilation
Assess bowel function
routinely
Narcan is antidote to reverse
respiration depression or coma
University of Evansville
Department of Nursing and Health Sciences
Drug Dispensing Sheet
Date____________________
Allergies:
Priority Nursing Diagnosis:
Long and Short term goals (must be measurable):
Interventions:
MEDICATION WITH
INDIVIDUAL DESIRED
PRESCRIBED DOSEAGE
EFFECT OF DRUG FOR
CLASSIFICATION OF THE
THIS PATIENT
DRUG
USUAL DOSE/SAFE DOSE
AND ADMINISTRATION
Brand Name: Lortab 7.5/500
Decrease in severity of
Generic Name: Hydrocodone
moderate pain
acetaminophen
Classification:Opioid
analgesics
Route and dosage: 2.5-10 mg
every 3-6 hrs
Page _____ of ______
Student ____Tammy Barton_______________________
Binds to opiate receptors in the
CNS. Alter the perception of
and response to painful stimuli
while producing generalized
CNS depression.
NURSING IMPLICATIONS/
CONSIDERATIONS FOR
THIS PATIENT
EVALUATION OF DESIRED
EFFECT FOR THE PATIENT.
INCLUDING ASSESSMENT,
LAB RESULTS AND
PROCEDURES
May cause confusion,
dizziness, sedation, euphoria,
hallucinations, headache,
unusual dreams, blurred vision,
diplopic, miosis, respiratory
depression, hypotension,
bradycardia, constipation,
dyspepsia, nausea, urinary
retention, sweating.
Prolonged use may lead to
physical and psychological
dependence and or tolerance.
Access type, location, and
intensity of pain prior to and 1
hour after giving.
Interacts with MAO inhibitors
producing severe unpredictable
reactions. Additive CNS
depression with alcohol,
antihistamines, and
sedative/hypnotics
University of Evansville
Page _____ of ______
Department of Nursing and Health Sciences
Drug Dispensing Sheet
Student __Tammy Barton__________________________
Date_________________________
Allergies:
Priority Nursing Diagnosis:
Long and Short term goals (must be measurable):
Interventions:
MEDICATION WITH
INDIVIDUAL DESIRED
PRESCRIBED DOSEAGE
EFFECT OF DRUG FOR
CLASSIFICATION OF THE
THIS PATIENT
DRUG
USUAL DOSE/SAFE DOSE
AND ADMINISTRATION
Brand Name: Toradol
Short term management of pain
Generic Name: Ketorolac
not to exceed 5 day total for all
routes
Classification: Nonsteroidal
anti-inflammatory agents,
nonopioid analgesics
Route and dosage: 15 mg IV
every 6 hrs PRN for
breakthrough pain
Inhibits prostaglandin synthesis
producing peripherally
mediated analgesia.
NURSING IMPLICATIONS/
CONSIDERATIONS FOR
THIS PATIENT
EVALUATION OF DESIRED
EFFECT FOR THE PATIENT.
INCLUDING ASSESSMENT,
LAB RESULTS AND
PROCEDURES
May cause drowsiness,
abnormal thinking, dizziness,
euphoria, headache, asthma,
edema, GI bleed, abnormal
taste, diarrhea, dry mouth, renal
toxicity, sweating, urinary
frequency, GI pin, nausea,
dermatitis, Stevens-Johnson
syndrome, prolonged bleeding
time
Access pt for hx of GI bleeds,
asthma.
Assess type of pain location,
intensity before and after
administration.
Assess for adverse reactions
such as rash, adverse oral
effects such as sores in the
mucosa.
University of Evansville
Page _____ of ______
Department of Nursing and Health Sciences
Drug Dispensing Sheet
Student ___Tammy Barton_________________________
Date________________________
Allergies:
Priority Nursing Diagnosis:
Long and Short term goals (must be measurable):
Interventions:
MEDICATION WITH
INDIVIDUAL DESIRED
PRESCRIBED DOSEAGE
EFFECT OF DRUG FOR
CLASSIFICATION OF THE
THIS PATIENT
DRUG
USUAL DOSE/SAFE DOSE
AND ADMINISTRATION
Brand Name: Ultram
Treatment for moderate to
Generic Name: Tramadol
moderately severe pain
Classification: Analgesics
(centrally acting)
Route and Dosage: 50-100 mg
every 4-6 hrs not to exceed
400mg/day or 300mg/day for
people over 75
Binds to mu-opioid receptors.
Inhibit its reuptake of serotonin
and nor epinephrine in the CNS
Decrease pain
NURSING IMPLICATIONS/
CONSIDERATIONS FOR
THIS PATIENT
EVALUATION OF DESIRED
EFFECT FOR THE PATIENT.
INCLUDING ASSESSMENT,
LAB RESULTS AND
PROCEDURES
May cause dizziness, headache,
somnolence, anxiety,
confusion, malaise, weakness,
flatulence, urinary retention,
sweating. abdominal pain, dry
mouth, diarrhea, anorexia,
vomiting
Assess type, location, and
intensity of pain before
administration
Assess b/p and R rate before
and during treatment.
Assess bowel functions
University of Evansville
Page _____ of ______
Department of Nursing and Health Sciences
Drug Dispensing Sheet
Student ___Tammy Barton_________________________
Date________________________
Allergies:
Priority Nursing Diagnosis:
Long and Short term goals (must be measurable):
Interventions:
MEDICATION WITH
INDIVIDUAL DESIRED
PRESCRIBED DOSEAGE
EFFECT OF DRUG FOR
CLASSIFICATION OF THE
THIS PATIENT
DRUG
USUAL DOSE/SAFE DOSE
AND ADMINISTRATION
Brand Name: Ultracet
Decrease pain.
Generic Name: Tramadol and
acetaminophen
Treatment for moderate and
moderately severe pain
Classification: Analgesics
Route and Dosage: 37.5mg of
tramadol and 325mg of
acetaminophen
Binds to mu-opioids receptors.
Inhibit its reuptake of serotonin
and nor epinephrine in the CNS
NURSING IMPLICATIONS/
CONSIDERATIONS FOR
THIS PATIENT
EVALUATION OF DESIRED
EFFECT FOR THE PATIENT.
INCLUDING ASSESSMENT,
LAB RESULTS AND
PROCEDURES
May cause dizziness, headache,
somnolence, anxiety,
confusion, malaise, weakness,
flatulence, urinary retention,
sweating. abdominal pain, dry
mouth, diarrhea, anorexia,
vomiting
Assess type, location, and
intensity of pain before
administration
Assess b/p and R rate before
and during treatment.
University of Evansville
Page _____ of ______
Department of Nursing and Health Sciences
Drug Dispensing Sheet
Student ___Tammy Barton_________________________
Date_________________________
Allergies:
Priority Nursing Diagnosis:
Long and Short term goals (must be measurable):
Interventions:
MEDICATION WITH
INDIVIDUAL DESIRED
PRESCRIBED DOSEAGE
EFFECT OF DRUG FOR
CLASSIFICATION OF THE
THIS PATIENT
DRUG
USUAL DOSE/SAFE DOSE
AND ADMINISTRATION
Brand Name: Percocet
To relieve moderate to severe
Generic Name: Oxycodone
pain
with acetaminophen
Classification: opioid
Decrease in severity of pain
analgesics
without significant alterations
in LOC or R status
Schedule II
Dosages:
Use with caution in pts with
Adult: > 50kg 5-10mg PO
head trauma, increased
every 3-4 hrs may give
intracranial pressure, severe
controlled release every 12 hrs renal, hepatic or pulmonary
Rectal (adults) 10-40mg 3-4
disease; hypothyroidism;
times a day
adrenal insufficiency
Tablets: 2.5 mg/325mg,
Adult: < 50kg or child 612yrs 1.25mg PO every 6 hrs
2.5 mg/400mg, 5mg/325mg
or 0.2 mg/kg every 3-4 hrs
5mg/400mg, 7.5mg/400mg,
Child >12 2.5 mg PO every
7.5mg/ 500mg, 10mg/ 325mg
6hrs
10mg/400mg, 10mg/650mg
NURSING IMPLICATIONS/
CONSIDERATIONS FOR
THIS PATIENT
EVALUATION OF DESIRED
EFFECT FOR THE PATIENT.
INCLUDING ASSESSMENT,
LAB RESULTS AND
PROCEDURES
Prolonged use can lead to
physical and psychological
dependence and tolerance
Constipation may become an
issue, increase fluid and fiber
intake
Narcan is antidote for
respiratory depression or
coma
Regular administered doses
may be more effective than prn
doses
Controlled release tablets
should be swallowed whole; do
not crush, break or chew (can
lead to rapid release and
absorption of a fatal dose)
Assess type, location, and
intensity of pain prior to and 1
hour after giving
Assess b/p, P, R, before and
after giving, if R is <10/min
assess level of sedation
Assess bowel sounds regularly
May increase plasma amylase
and lipase levels